ANN ARBOR - The University of Michigan has named its bipolar disorder research program for Heinz Prechter, in honor of a new gift commitment of up to $5 million by the World Heritage Foundation - Prechter Family Fund. But the gift comes with a challenge to others who care about bipolar disorder: The Prechter family
ANN ARBOR - Genomenon announced a $1.8 milion grant awarded by the National Institutes of Health will fund Genomenon’s further innovation in genomic analysis, streamlining the literature research and curation process leading to faster patient diagnosis. “This grant recognizes the solid approach and great potential of Genomenon’s technology to drive rapid improvements in automating accurate gene
ANN ARBOR - ONL Therapeutics, Inc., a biopharmaceutical company developing novel therapies for preserving sight in a range of retinal diseases, Tuesday announced new appointments and promotions involving the company’s board of directors and management team. The company has appointed Christine (Chris) Gibbons as a new, independent member of its board of directors, replacing departing
ANN ARBOR - Gemphire Therapeutics Inc., a clinical-stage biopharmaceutical company, announced that it has closed on the sale of 1.3 million shares of stock to a select group of accredited investors that will raise about $12.5 million, providing cash flow through 2018. Gemphire Therapeutics will use the money to fund development costs, the company said
ANN ARBOR - On Thursday, MichBio will host a networking breakfast and moderated discussion at the Kensington Hotel on State Street in Ann Arbor with acclaimed networking guru Kelly Hoey, whose recent book BUILD YOUR DREAM NETWORK helps readers build and activate powerful networks to achieve both their long and short-term goals. Hoey is a
PLYMOUTH - Recent media coverage of hospitals penalized for high rates of hospital-acquired infections brings into focus one of the most preventable causes of such infections: unclean surgical instruments. Ensuring the cleanliness of surgical instruments has long been a vexing and troublesome issue for health care facilities. Until recently, however, most of the population was
ANN ARBOR - Enzo Life Sciences has introduced a cancer library, a collection of 275 ready-to-use compounds for use in cancer inhibitor screening and assay development. The SCREEN-WELL Cancer Library is comprised of compounds that are dissolved at 10 mM in DMSO and aliquoted at 100 µL per well in deep 96-well plates. It contains
ROYAL OAK - Alexa Jones, co-founder and CEO of TheraB Medical, a Michigan State University spin-out, is an early stage wearable technology for infant jaundice. This medical device, available in hospitals and for home care, uses light to treat infant jaundice, that affects up to 60 percent of new borns. The product, Snuglit, has the
ANN ARBOR - For the first time, human stem cells have been coaxed to begin to form amniotic sac tissue in a laboratory-based model mimicking the wall of the uterus. The new study, performed at the University of Michigan and reported in Nature Materials, provides the first opportunity to study the development of amnion, an
GRAND RAPIDS — Drug developer Tetra Discovery Partners LLC said it’s closed on $5 million in new venture capital funding. The Apjohn Group in Kalamazoo and Holland-based Grand Angels led the investment with San Francisco-based venture firm Dolby Family Ventures. The closing elevated a Series A financing for Tetra Discovery to $7.27 million to support development
